NEU 3.17% $20.86 neuren pharmaceuticals limited

AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare...

  1. 553 Posts.
    lightbulb Created with Sketch. 298
    AstraZeneca to acquire Amolyt Pharma,
    expanding late-stage rare disease pipeline

    PUBLISHED14 March 2024


    Amolyt development portfolio includes Phase III asset with potential to address
    significant unmet need in patients with chronic hypoparathyroidism

    Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond
    complement inhibition, building on company’s success in bone metabolism and
    opportunity in rare endocrinology


    https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-to-acquire-amolyt.html
    Last edited by Piton72: 14/03/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.86
Change
0.640(3.17%)
Mkt cap ! $2.666B
Open High Low Value Volume
$20.45 $21.10 $20.39 $9.299M 447.5K

Buyers (Bids)

No. Vol. Price($)
1 671 $20.85
 

Sellers (Offers)

Price($) Vol. No.
$20.86 262 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.